| Long name: |
Polyclonal Antibody to Apolipoprotein C2 (APOC2) |
| Antigen: |
Apolipoprotein C2 (APOC2) |
| Other names: |
Apolipoprotein C-II, Apolipoprotein C2, apolipoprotein C-II, apolipoprotein C-II, apolipoprotein C2, apolipoprotein C-II |
| Gene name: |
APOC2, Apolipoprotein C2 (APOC2) |
| Gene synonims: |
APC2, APO-CII, APOC-II, APOC2, Apo-CII, ApoC-II, APOC2 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Due to limitted amount of tested species we cannot guarantee that no crossreactivity will occur |
| Specificity: |
, APOC2, It has been selected for its ability to recognize APOC2 in immunohistochemical staining andwestern blotting, The antibody is a rabbit polyclonal antibody raised against APOC2, This is an antibody designed to detect Apolipoprotein C2 (APOC2) |
| Purification method: |
This antibody was purified via Affinity Chromatography |
| Form/Appearance: |
containing 0, pH7, 02% NaN3, 4, 50% glycerol, Supplied as solution form in PBS |
| Concentration: |
2mg/ml |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, ELISA, IFA, Immunohistochemistry (IHC) - Formalin/Paraffin, Western Blot (WB), Immunocytochemistry (ICC) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
Apolipoprotein C2 (APOC2) |
| Short name: |
Anti- Apolipoprotein C2 (APOC2) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to Apolipoprotein complement component 2 (apolipoprotein C-II) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APO-CII and APOC-II, APOC2 and IDBG-306903 and ENSG00000234906 and 344, APOC2 and IDBG-639315 and ENSBTAG00000020558 and 618039, ARMD14 and CO2, Apoc2 and IDBG-151996 and ENSMUSG00000002992 and 11813, C2 and IDBG-124824 and ENSG00000166278 and 101928623, C2 and IDBG-174547 and ENSMUSG00000024371 and 12263, C2 and IDBG-633680 and ENSBTAG00000007450 and 515440, Extracellular, Extracellular, apolipoprotein C-II, classical pathway and biological process this GO :0007584 and response to nutrient and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0045087 and innate immune response and biological process this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, lipoprotein lipase activator activity, protein binding, this GO :0001523 and retinoid metabolic process and biological process this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0003824 and catalytic activity and molecular function this GO :0004252 and serine-type endopeptidase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006508 and proteolysis and biological process this GO :0006956 and complement activation and biological process this GO :0006958 and complement activation, this GO :0003824 : catalytic activity, this GO :0003824 : catalytic activity and also this GO :0004252 : serine-type endopeptidase activity and also this GO :0005515 : protein binding, this GO :0004252 : serine-type endopeptidase activity, this GO :0005515 : protein binding, this GO :0008047 : enzyme activator activity, this GO :0008047 : enzyme activator activity and also this GO :0008289 : lipid binding and also this GO :0016004 : phospholipase activator activity and also this GO :0042803 : protein homodimerization activity and also this GO :0043274 : phospholipase binding and also this GO :0055102 : lipase inhibitor activity and also this GO :0060230 : lipoprotein lipase activator activity, this GO :0008289 : lipid binding, this GO :0016004 : phospholipase activator activity, this GO :0042803 : protein homodimerization activity, this GO :0043274 : phospholipase binding, this GO :0055102 : lipase inhibitor activity, this GO :0060230 : lipoprotein lipase activator activity, visible light and biological process this GO :0008047 and enzyme activator activity and molecular function this GO :0008289 and lipid binding and molecular function this GO :0010518 and positive regulation of phospholipase activity and biological process this GO :0010898 and positive regulation of triglyceride catabolic process and biological process this GO :0010902 and positive regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0016004 and phospholipase activator activity and molecular function this GO :0016042 and lipid catabolic process and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034362 and low-density lipoprotein particle and cellular component this GO :0034363 and intermediate-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034371 and chylomicron remodeling and biological process this GO :0034372 and very-low-density lipoprotein particle remodeling and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043274 and phospholipase binding and molecular function this GO :0043691 and reverse cholesterol transport and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045723 and positive regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0060697 and positive regulation of phospholipid catabolic process and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070328 and triglyceride homeostasis and biological process, 717, complement component 2 |
| Identity: |
609 |
| Gene: |
APOC2 |
More about : APOC2 |
| Long gene name: |
apolipoprotein C2 |
| Synonyms gene name: |
apolipoprotein C-II |
| Locus: |
19q13, 32 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
X00568 |
| Entrez gene record: |
344 |
| RefSeq identity: |
NM_000483 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000180847 |